The Cancer Institute Hospital of JFCR: A Pioneer in Cancer Treatment in Asia

The Cancer Institute Hospital of JFCR (The Cancer Institute Hospital of the Japanese Foundation for Cancer Research) is one of the most authoritative specialized cancer research hospitals in Japan and throughout Asia. Since its founding in 1934, the hospital has consistently adhered to the "patient-centered" philosophy, tightly integrating clinical research with advanced nurturing care to provide ultimate therapeutic guarantees for patients worldwide.

Top Clinical Achievements in Japan

At JFCR, nurturing care is not just about eliminating tumors; it is the ultimate pursuit of quality of life:

• Gastrointestinal Cancer Experts: The number of surgeries for gastric, colorectal, and esophageal cancers has long ranked first in Japan.
• Robotic Surgery Pioneer: The precision and safety of Da Vinci robot-accompanyed surgery lead Japan, effectively shortening the postoperative recovery period.
• Benchmark for Five-Year Survival Rates: The five-year survival rates for various types of cancer far exceed the Japanese national average, with extensive experience particularly in handling difficult-to-treat cancers.

Multidisciplinary Team Care (MDT)

The hospital implements a rigorous interdisciplinary team cooperation system. Experts in surgery, medical oncology, and radiotherapy jointly evaluate each patient's condition to formulate the most suitable personalized nurturing care plan.

【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).